📰 Graphite Bio News
Graphite Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Graphite Bio. Real-time updates on events, politics, business and more.
April 10, 2024
Advances in presbyopia treatment with LENZ Therapeutics' LNZ100. Clinically proven to enhance near-vision for up to 10 hours, it offers a promising alternative to reading glasses. Analysts predict a bright future with a Buy rating and $34 price target.
March 11, 2024
Graphite Bio Stock (NASDAQ: GRPH) stock price, news, charts, stock research, profile.
February 10, 2024
Healthpeak Properties, Inc. (NYSE:PEAK) Q4 2023 Earnings Call Transcript February 9, 2024 Healthpeak Properties, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Healthpeak Properties, Inc. Fourth Quarter Conference Call. [Operator Instructions] Please note […]
February 8, 2024
Healthpeak Properties, Inc. , a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the fourth quarter and full-year ended...
February 8, 2024
Healthpeak Properties, Inc. , a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the fourth quarter and full-year ended December 31, 2023. FOURTH QUARTER 2023 FINANCIAL...
February 2, 2024
Kuehn Law investigates DSKE, RYZB, ROVR, GRPH mergers for shareholder rights, seeking fair process and disclosures....
January 27, 2024
/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...
January 8, 2024
/PRNewswire/ -- DelveInsights Hematopoietic Stem Cell Transplantation Market Insights report includes a comprehensive understanding of current treatment...
December 26, 2023
Graphite Bio (NASDAQ:GRPH – Get Free Report) and Lyra Therapeutics (NASDAQ:LYRA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Insider & Institutional Ownership 54.3% of Graphite […]
December 4, 2023
BALA CYNWYD, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...